A multifaceted intervention to improve syphilis screening and treatment in pregnant women in Kinshasa, Democratic Republic of the Congo and in Lusaka, Zambia: a cluster randomised controlled trial

Fernando Althabe, Elwyn Chomba, Antoinette K Tshefu, Ernest Banda, María Belizán, Eduardo Bergel, Mabel Berrueta, Jane Bertrand, Carl Bose, Maria Luisa Cafferata, Waldemar A Carlo, Alvaro Ciganda, France Donnay, Ezequiel García Elorrio, Luz Gibbons, Karen Klein, Jerker Liljestrand, Paul D Lusamba, Arlette K Mavila, Agustina Mazzoni, Dalau M Nkamba, Friday H Mwanakalanga, Abigail Mwapule Tembo, Musaku Mwenechanya, Lee Pyne-Mercier, Cintia Spira, Jean D Wetshikoy, Xu Xiong, Pierre Buekens, Fernando Althabe, Elwyn Chomba, Antoinette K Tshefu, Ernest Banda, María Belizán, Eduardo Bergel, Mabel Berrueta, Jane Bertrand, Carl Bose, Maria Luisa Cafferata, Waldemar A Carlo, Alvaro Ciganda, France Donnay, Ezequiel García Elorrio, Luz Gibbons, Karen Klein, Jerker Liljestrand, Paul D Lusamba, Arlette K Mavila, Agustina Mazzoni, Dalau M Nkamba, Friday H Mwanakalanga, Abigail Mwapule Tembo, Musaku Mwenechanya, Lee Pyne-Mercier, Cintia Spira, Jean D Wetshikoy, Xu Xiong, Pierre Buekens

Abstract

Background: Despite international recommendations, coverage of syphilis testing in pregnant women and treatment of those found seropositive remains limited in sub-Saharan Africa. We assessed whether combining the provision of supplies with a behavioural intervention was more effective than providing supplies only, to improve syphilis screening and treatment during antenatal care.

Methods: In this 18-month, cluster randomised controlled trial, we randomly assigned (1:1) 26 urban antenatal care clinics in Kinshasa, Democratic Republic of the Congo, and Lusaka, Zambia, to receive a behavioural intervention (opinion leader selection, academic detailing visits, reminders, audits and feedback, and supportive supervision) plus supplies for syphilis testing and treatment (intervention group) or to receive supplies only (control group). The primary outcomes were proportion of pregnant women who had syphilis screening out of the total who attended the clinic; and the proportion of women who had treatment with benzathine benzylpenicillin out of those who tested positive for syphilis at their first antenatal care visit. This trial is registered at ClinicalTrials.gov, number NCT02353117.

Findings: The 18-month study period was Feb 1, 2016, to July 14, 2017. 18 357 women were enrolled at the 13 intervention clinics and 17 679 women were enrolled at the 13 control clinics at their first antenatal care visit. Syphilis screening was done in a median of 99·9% (IQR 99·0-100·0) of women in the intervention clinics and 93·8% (85·0-98·9) in the control clinics (absolute difference 6·1% [95% CI 1·1-14·1]; p=0·00092). Syphilis treatment at the first visit was done in a median of 100% (IQR 99·7-100·0) of seropositive women in intervention clinics and 43·2% (2·6-83·2) of seropositive women in control clinics (absolute difference 56·8% [12·8-99·0]; p=0·0028).

Interpretation: A behavioural intervention, together with the provision of supplies, can lead to more than 95% of women being screened and treated for syphilis. The sole provision of supplies is sufficient to reach such levels of screening coverage but is not sufficient to ensure high levels of treatment.

Funding: Bill & Melinda Gates Foundation.

Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Trial profile
Figure 2
Figure 2
Syphilis screening and treatment across the clinics (A) Proportions of women screened at each of the 26 clinics. Numbers below bars are number of women screened over number of pregnant women attending clinic. (B) Proportions of women treated at the 23 clinics. Three clinics had no seropositive women, so proportion treated could not be calculated, and these clinics are not included on the graph. Numbers below bars are number of women treated over number of women who tested seropositive for syphilis.
Figure 3
Figure 3
Syphilis screening and treatment by study month Proportions of women screened of total number of pregnant women attending clinic (A) and proportions of women treated of total number of women who tested seropositive for syphilis (B) over the baseline and follow-up periods. The grey area indicates when the intervention was implemented, separating the baseline and post-intervention periods.

References

    1. Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ. 2013;91:217–226.
    1. De Santis M, De Luca C, Mappa I. Syphilis infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol. 2012;2012:430585.
    1. Wijesooriya NS, Rochat RW, Kamb ML. Global burden of maternal and congenital syphilis in 2008 and 2012: a health systems modelling study. Lancet Glob Health. 2016;4:e525–e533.
    1. WHO . second edition. World Health Organization; Geneva: 2017. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis.
    1. WHO . World Health Organization; Geneva: 2017. WHO guideline on syphilis screening and treatment for pregnant women.
    1. Betrán AP, Bergel E, Griffin S. Provision of medical supply kits to improve quality of antenatal care in Mozambique: a stepped-wedge cluster randomised trial. Lancet Glob Health. 2018;6:e57–e65.
    1. Nurse-Findlay S, Taylor MM, Savage M. Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: an evaluation from multi-country surveys and stakeholder interviews. PLoS Med. 2017;14:e1002473.
    1. Althabe F, Buekens P, Bergel E. A behavioral intervention to improve obstetrical care. N Engl J Med. 2008;358:1929–1940.
    1. Althabe F, Alemán A, Berrueta M. A multifaceted strategy to implement brief smoking cessation counseling during antenatal care in Argentina and Uruguay: a cluster randomized trial. Nicotine Tob Res. 2016;18:1083–1092.
    1. Althabe F, Belizán JM, McClure EM. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet. 2015;385:629–639.
    1. Berrueta M, Cafferata ML, Mwenechanya M. Syphilis screening and treatment in pregnant women in Kinshasa, Democratic Republic of the Congo and in Lusaka, Zambia: a cross-sectional study. Gates Open Res. 2017;1:13.
    1. Taljaard M, Weijer C, Grimshaw JM, Eccles MP. The Ottawa statement on the ethical design and conduct of cluster randomised trials: precis for researchers and research ethics committees. BMJ. 2013;346:f2838.
    1. Berrueta M, Cafferata ML, Mwenechanya M. Syphilis screening and treatment in pregnant women in Kinshasa, Democratic Republic of the Congo and in Lusaka, Zambia: a cross-sectional study. Gates Open Res. 2017;1:13.
    1. Ivers NM, Halperin IJ, Barnsley J. Allocation techniques for balance at baseline in cluster randomized trials: a methodological review. Trials. 2012;13:120.
    1. Rogers EM. 3rd edn. Free Press; New York: 1983. Diffusion of innovations.
    1. Nkamba D, Mwenechanya M, Kilonga AM. Barriers and facilitators to the implementation of antenatal syphilis screening and treatment for the prevention of congenital syphilis in the Democratic Republic of Congo and Zambia: results of qualitative formative research. BMC Health Serv Res. 2017;17:556.
    1. Hiss RG, MacDonald R, Davis WK. Proceedings of the 17th Annual Conference on Research in Medical Education. Assocation of American Medical Colleges; Washington, DC: 1978. Identification of physician educational influences in small community hospital; pp. 283–288.
    1. Hoffmann TC, Glasziou PP, Boutron I. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.
    1. Hollander M, Wolfe DA, Chicken E. 3rd edn. John Wiley; New York: 2013. Nonparametric statistical methods.
    1. Raab GM, Butcherb I. Randomization inference for balanced cluster-randomized trials. Clin Trials. 2005;2:130–140.
    1. Gliddon HD, Peeling RW, Kamb ML, Toskin I, Wi TE, Taylor MM. A systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis. Sex Transm Infect. 2017;93:S3–S15.
    1. Myer L, Wilkinson D, Lombard C, Zuma K, Rotchford K, Karim SS. Impact of on-site testing for maternal syphilis on treatment delays, treatment rates, and perinatal mortality in rural South Africa: a randomised controlled trial. Sex Transm Infect. 2003;79:208–213.
    1. Munkhuu B, Liabsuetrakul T, Chongsuvivatwong V, McNeil E, Janchiv R. One-stop service for antenatal syphilis screening and prevention of congenital syphilis in Ulaanbaatar, Mongolia: a cluster randomized trial. Sex Transm Dis. 2009;36:714–720.
    1. Levi J, Raymond A, Pozniak A, Vernazza P, Kohler P, Hill A. Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades. BMJ Glob Health. 2016;1:e000010.
    1. Chin DP, Hanson CL. Finding the missing tuberculosis patients. J Infect Dis. 2017;216(suppl 7):S675–SS78.
    1. Semitala FC, Camlin CS, Wallenta J. Understanding uptake of an intervention to accelerate antiretroviral therapy initiation in Uganda via qualitative inquiry. J Int AIDS Soc. 2017;20:4.
    1. Amanyire G, Semitala FC, Namusobya J. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. Lancet HIV. 2016;3:e539–e548.

Source: PubMed

3
Abonneren